Tango Therapeutics TNGX
NASDAQ TNGX
$24.45 -0.50 (-2.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tango Therapeutics (TNGX) Liabilities and Shareholders Equity (2020 - 2026)

Updated

Tango Therapeutics (TNGX) reported Liabilities and Shareholders Equity of $1.07 billion for Q2 2026, up 351.4% from $237.89 million a year earlier and up 146.4% from the prior quarter.

Analysis

Tango Therapeutics (TNGX) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Tango Therapeutics posted Liabilities and Shareholders Equity of $398.69 million, up 26.0% from FY2024.

  • Liabilities and Shareholders Equity has a five-year compound annual growth rate of 14.0% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $316.49 million in FY2024 (-21.4%), $402.57 million in FY2023 (-7.8%), $436.47 million in FY2022 (-12.7%) and $500.16 million in FY2021 (+141.3%).
  • The Q2 2026 figure ranks as the highest quarterly Liabilities and Shareholders Equity in data going back to Q3 2020.
  • Year over year, Liabilities and Shareholders Equity has now increased in each of the last three quarters, with growth averaging 35.8% over the last eight quarters.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q2 2026 (growth of 351.4%); the low point was Q3 2025 (a decline of 40.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $435.79 million (Q1 2026), $398.69 million (Q4 2025) and $210.14 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Tango Therapeutics 4.20 Bn 2.31 Bn - 1.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.07 Bn
Mar 31, 2026 435.79 Mn
Dec 31, 2025 398.69 Mn
Sep 30, 2025 210.14 Mn
Jun 30, 2025 237.89 Mn
Mar 31, 2025 274.31 Mn
Dec 31, 2024 316.49 Mn
Sep 30, 2024 352.42 Mn
Jun 30, 2024 381.45 Mn
Mar 31, 2024 406.22 Mn
Dec 31, 2023 402.57 Mn
Sep 30, 2023 428.19 Mn
Jun 30, 2023 379.33 Mn
Mar 31, 2023 403.77 Mn
Dec 31, 2022 436.47 Mn
Sep 30, 2022 464.16 Mn
Jun 30, 2022 448.40 Mn
Mar 31, 2022 471.53 Mn
Dec 31, 2021 500.16 Mn
Sep 30, 2021 530.14 Mn
API Access

Tango Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TNGX&period=max&api_key=YOUR_API_KEY